SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.1% | 6.2% | -21.3% | 34.3% | 3.5% | 15.9% | 93.9% | 79.2% | -51.6% | 23.7% | -15.7% | -132.2% | |
| 12.9% | 9.7% | 7.3% | 2.8% | 2.2% | 2.0% | 0.8% | 0.4% | 10.5% | 32.3% | 31.4% | 26.9% | |
| 0.5% | 1.4% | 3.3% | 0.6% | 1.9% | 1.2% | 2.0% | 0.0% | 10.0% | 0.0% | – | – | |
| 1.4% | 1.4% | 0.2% | 5.2% | 10.9% | 7.1% | 16.1% | – | – | – | – | – | |
| -30.0% | -3.3% | -28.0% | 11.5% | -19.2% | -11.5% | 55.4% | 2.4% | -72.4% | 62.0% | -34.2% | -97.6% | |
| 17.3% | 7.9% | 17.5% | 6.8% | 2.4% | 4.3% | 25.0% | 3.7% | 27.0% | 32.5% | 27.0% | 12.7% | |
| -17.5% | -6.7% | -16.3% | -6.8% | -11.0% | -17.3% | -40.1% | -15.6% | -385.9% | -652.8% | – | 1,136.4% | |
| 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 9.7% | 17.6% | 73.2% | 262.1% | 910.2% | |
| 0.9% | 1.1% | 0.4% | 1.0% | 37.2% | – | – | 0.1% | – | – | – | – | |
| 1.9% | -37.8% | 28.5% | -3.2% | -10.9% | -0.5% | 112.4% | -0.1% | -0.3% | 53.3% | 34.0% | 25.8% | |
| 8.4% | -35.9% | 38.4% | -0.8% | 27.9% | 0.7% | 116.0% | -9.8% | -16.2% | -17.0% | -228.0% | -889.8% | |
| -26.6% | -38.5% | -1.9% | 29.0% | 18.4% | -0.9% | 175.1% | 54.6% | -491.3% | -671.7% | -145.8% | 143.6% | |
| -33.4% | -1.6% | -38.8% | 27.4% | 1.0% | 11.6% | 68.9% | 75.5% | -78.7% | -9.3% | -42.7% | -144.9% |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.